United Kingdom · 
What does MVM Life Science Partners invest in?
MVM Life Science Partners invests most often at Series B and Series C (59% of the rounds on record).
MVM Life Science Partners highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series B and Series C: 59% of its rounds
- 03
Sole investor in 5 rounds, median $10M
- 04
4 exits from the portfolio
What they do
We provide equity to companies with high growth potential.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $20M – $100M as they say
- Stages
- DebtGrowthSeedSeries A
- Based in
- LONDON, United Kingdom
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first36 appearances
- 2026
1 round
- Jun
- 2025
3 rounds
- Nov
- Aug
- Jan
- 2024
1 round
- Dec
- 2023
1 round
- Mar
- 2018
1 round
- Sept
- 2017
1 round
- May
- 2016
1 round
- Dec
- 2015
1 round
- Apr
- 2014
4 rounds
- Jun
- May
- Apr
- Feb
- 2013
2 rounds
- Jun
- Jan
- 2012
2 rounds
- Mar
- Jan
- 2011
3 rounds
- Aug
- Jul
- Jul
- 2010
3 rounds
- Nov
- Jul
- Jan
- 2009
1 round
- Nov
- 2008
1 round
- Aug
- 2007
4 rounds
- Dec
- Aug
- Jun
- Jun
- 2006
1 round
- Nov
- 2005
1 round
- May
- 2004
1 round
- Mar
- 2003
3 rounds
- Sept
- May
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration9 named
AIAna Isabella MihovMemberiForm ADV
EBEric BednarskiMemberiForm ADV
HRHugo Roy Francis HarrodMemberiForm ADV
JYJack Yuuki TanakaMemberiForm ADV
KXKevin Xu ChengMemberiForm ADV
KEKyle Edward DempseyMemberiForm ADV
NJNeil James AkhurstMemberiForm ADV
STStephen Thomas ReedersMemberiForm ADV
TTThomas Theodore CasdagliMemberiForm ADV
We also hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$1.1Bgross assets of its funds, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- MVM Partners LLP
- SEC number
- CRD 159225
Exits from the portfolio
Companies it backed that were later bought or listed4 in all
Heptares TherapeuticsBought by SoseiUndisclosedFeb 2015
PregLemBought by Richter GroupUndisclosedOct 2010
Oxxon TherapeuticsBought by Oxford BioMedicaUndisclosedMar 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.